Latest News

GeoVax Publishes Ebola Vaccine Study Results in Nature’s Scientific Reports
100% Single-Dose Protection Observed in Lethal Challenge Model GeoVax Labs, Inc. (OTCQB: GOVX), a b...
Continue Reading...
GeoVax and Vaxeal to Collaborate on Cancer Immunotherapy Program
GeoVax Expanding Application of its MVA-VLP Vaccine Technology with Multiple Collaborations in Immun...
Continue Reading...
GeoVax to Present During China Showcase at Biotech Showcase 2018
Part of Larger Corporate Partnering Effort During the J.P. Morgan 36th Annual Healthcare Conference ...
Continue Reading...